Clinical Trials for Women
(continued)
Additional Clinical Trials Resources:
Check out the following references for additional sites that can provide useful
information. It is generally helpful to contact the national patient
advocacy group for the relevant condition (American Heart Association,
American Cancer Society, National Association of Breast Cancer Organizations,
National Osteoporosis Foundation, etc.):
- Pharmaceutical Researchers
and Manufacturers Association (PhRMA)
PhRMA is the national trade organization for the US pharmaceutical
industry. Their reports on drugs in development for women, drugs in development
for cancer, and drugs in development for AIDs can be accessed at this site.
Recently, PhRMA has launched a new site: www.newmedicines.org from
which people can access information about on-going pharmaceutical company-sponsored
clinical trials in a number of diseases.
- Food
and Drug Administration (FDA)
The Food and Drug Administration (FDA) is responsible for review of safety
and efficacy data for all new drug applications (NDA's), as well as approved
prescription and over the counter products.
- National Institutes of Health (NIH)
The NIH is the governmental body responsible for conducting clinical research. Their website has abundant information about clinical trials in general, as well as specific ongoing clinical trials. They also publish a booklet called "What are clinical trials all about?" To request a copy, call 800-422-6237.
- National Cancer
Institute
This is the division of the National Institutes of Health (NIH) responsible
for cancer-related clinical trials and related information.
- Society for Women's
Health Research (SWHR)
The Society is the only national non-profit organization dedicated to
educating researchers, policymakers, clinicians, and patients about the importance
of including women in clinical trials.
The Society recently launched a public education campaign, Some
Things Only A Woman Can Do, to educate women about the importance
of participating in medical research. Only with adequate numbers of women
in clinical trials can researchers perform the gender analysis necessary to
determine sex-based differences in drug reactions, progression of disease,
and health outcomes. As the number of women enrolled in clinical trials increases,
we can diminish the gender inequalities that exist in our scientific knowledge
of men's and women's biology. Dr. Donnica has served as a member of their
Board of Directors.
- Research!America
Research!America is the nation's leading non-profit, non-partisan voice for
making medical and health research a higher national priority. Its membership
represents more than 400 academic institutions, independent research laboratories,
teaching hospitals, private industries, professional societies, voluntary
health agencies and philanthropies. Research!America's mission is to make
medical and health research a much higher national priority. Dr. Donnica has
served as a member of their Board of Directors.
Created: 9/22/2001  - Donnica Moore, M.D.
|
Because women are now recognized to have different needs, different responses to diseases, and different responses to medicines, biomedical researchers ... are continuing to investigate medicines for prevention and treatment specifically in women.
|